Home › Myelofibrosis › Kansas › Kansas City
Myelofibrosis clinical trials in Kansas City, KS
3 studies for Myelofibrosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
RecruitingPhase 1
- University of Kansas Medical Center, Kansas City
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- University of Kansas Cancer Center, Kansas City
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US21, Kansas City
Myelofibrosis trials in other cities
- New York City, NY21 studies
- Houston, TX20 studies
- Boston, MA13 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Seattle, WA12 studies
- Tampa, FL11 studies
- Nashville, TN11 studies
- Miami, FL11 studies
- Salt Lake City, UT11 studies
- Ann Arbor, MI10 studies
- Atlanta, GA10 studies
Other studies in Kansas City
- Interstitial Lung Diseases13 studies
- Obesity13 studies
- Cystic Fibrosis13 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Heart Failure12 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease12 studies
- Breast Cancer12 studies
- Lung Cancer11 studies
- Bladder Cancer10 studies
- Asthma9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.